ArticleRSC advances2025
Label-free fluorescent probe based on upconversion nanoparticles for convenient detection of cytochrome c.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal levels of cytochrome c (Cyt c) are closely associated with various human diseases, including neurodegenerative disorders and cancers. Therefore, the quantitative detection of Cyt c holds significant value for both disease diagnosis and therapeutic efficacy assessment. Herein, we developed two novel label-free fluorescent probes for sensitive Cyt c detection based on upconversion nanoparticles: one functionalized with poly (ethylene glycol) ylated phospholipid (DSPE-PEG) alone, and the other co-functionalized DSPE-PEG combined with triphenylphosphine. The electrostatic interaction generates resulting in a quantifiable fluorescence quenching effect. The proposed method demonstrated excellent performance in the detection of Cyt c in complex matrices, including cell lysates and human blood sample. Notably, it offers significant advantages over conventional assays by simplifying sample preparation, reducing operational steps, and providing rapid response with distinct observable signals, showing great potential for clinical diagnosis and therapeutic monitoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.